Novabay Pharmaceuticals Stock Price on June 6, 2023

NBY Stock  USD 0.68  0.04  5.56%   
If you're considering investing in NovaBay Stock, it is important to understand the factors that can impact its price. As of today, the current price of NovaBay Pharmaceuticals stands at 0.68, as last reported on the 24th of November, with the highest price reaching 0.72 and the lowest price hitting 0.68 during the day. NovaBay Pharmaceuticals appears to be dangerous, given 3 months investment horizon. NovaBay Pharmaceuticals has Sharpe Ratio of 0.086, which conveys that the firm had a 0.086% return per unit of risk over the last 3 months. By analyzing NovaBay Pharmaceuticals' technical indicators, you can evaluate if the expected return of 0.65% is justified by implied risk. Please exercise NovaBay Pharmaceuticals' Downside Deviation of 3.62, mean deviation of 4.15, and Risk Adjusted Performance of 0.0749 to check out if our risk estimates are consistent with your expectations.
  
NovaBay Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.086

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsNBY
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 7.53
  actual daily
67
67% of assets are less volatile

Expected Return

 0.65
  actual daily
12
88% of assets have higher returns

Risk-Adjusted Return

 0.09
  actual daily
6
94% of assets perform better
Based on monthly moving average NovaBay Pharmaceuticals is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of NovaBay Pharmaceuticals by adding it to a well-diversified portfolio.

NovaBay Pharmaceuticals Valuation on June 6, 2023

It is possible to determine the worth of NovaBay Pharmaceuticals on a given historical date. On June 6, 2023 NovaBay was worth 22.05 at the beginning of the trading date compared to the closed value of 21.7. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of NovaBay Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find NovaBay Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of NovaBay Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against NovaBay Pharmaceuticals' related companies.
 Open High Low Close Volume
  21.35    22.33    21.35    21.36    1,227  
06/06/2023
  22.05    22.37    21.36    21.70    1,157  
  21.70    25.55    21.35    24.66    27,214  
Backtest NovaBay Pharmaceuticals  |  NovaBay Pharmaceuticals History  |  NovaBay Pharmaceuticals Valuation   PreviousNext  
Open Value
22.05
21.7
Closing Value
44.65
Upside

NovaBay Pharmaceuticals Trading Date Momentum on June 6, 2023

On June 07 2023 NovaBay Pharmaceuticals was traded for  24.66  at the closing time. Highest NovaBay Pharmaceuticals's price during the trading hours was 25.55  and the lowest price during the day was  21.35 . The net volume was 27.2 K. The overall trading history on the 7th of June contributed to the next trading period price jump. The trading delta at closing time to the next next day price was 13.64% . The trading delta at closing time to current price is 11.29% .

NovaBay Pharmaceuticals Fundamentals Correlations and Trends

By evaluating NovaBay Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among NovaBay Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. NovaBay financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About NovaBay Pharmaceuticals Stock history

NovaBay Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for NovaBay is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in NovaBay Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing NovaBay Pharmaceuticals stock prices may prove useful in developing a viable investing in NovaBay Pharmaceuticals
NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California. Novabay Pharmaceuticals operates under Biotechnology classification in the United States and is traded on AMEX Exchange. It employs 29 people.

NovaBay Pharmaceuticals Stock Technical Analysis

NovaBay Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of NovaBay Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of NovaBay Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

NovaBay Pharmaceuticals Period Price Range

Low
November 24, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

NovaBay Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NYSE MKT Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

NovaBay Pharmaceuticals November 24, 2024 Market Strength

Market strength indicators help investors to evaluate how NovaBay Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading NovaBay Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying NovaBay Pharmaceuticals stock market strength indicators, traders can identify NovaBay Pharmaceuticals entry and exit signals to maximize returns

NovaBay Pharmaceuticals Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for NovaBay Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of NovaBay Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of NovaBay to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for NovaBay Stock Analysis

When running NovaBay Pharmaceuticals' price analysis, check to measure NovaBay Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NovaBay Pharmaceuticals is operating at the current time. Most of NovaBay Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of NovaBay Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NovaBay Pharmaceuticals' price. Additionally, you may evaluate how the addition of NovaBay Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.